GlassScriptPhysician profile
Alexander Glogau
NPI 1851384077
$39,486.42
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33K · 2020: $1,540 · 2021: $5,020.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $31,873.69 | 2019-2020 | |
| Horizon Therapeutics Plc | $4,723.79 | 2019-2021 | |
| Stryker Corporation | $1,329.27 | 2019-2021 | |
| Acell, INC. | $491.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $371.85 | 2019-2021 | |
| Vericel Corporation | $150.17 | 2019-2021 | |
| Trice Medical, INC. | $143.46 | 2019 | |
| Smith+Nephew, INC. | $123.74 | 2019 | |
| Parcus Medical, LLC | $108.43 | 2020 | |
| Depuy Synthes Sales INC. | $74.64 | 2019 | |
| Ermi LLC | $32.00 | 2019 | |
| Integra Lifesciences Corporation | $30.89 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.83 | 2019 | |
| Orthofix Medical, INC. | $12.66 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Glogau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.